CEPHEID (CPHD)
CEPHEID Price: 38.47
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
Select a metric
Date range:
to
<Embed Chart>
Pro Save as Image
Pro Data Export
Copy the code below and paste
into the embed destination.
into the embed destination.
Attention
OK
CPHD Price Rankings
| Overall | 80th percentile | 1537 of 7690 |
| Sector | 88th percentile | 106 of 937 in Technology |
| Industry | 74th percentile | 15 of 58 in Scientific & Technical Instruments |
CPHD Price Range, Past 5 Years
| Minimum | 5.03 | Mar 20 2009 |
| Maximum | 44.91 | Feb 6 2012 |
| Average | 21.67 |
About Price
The price of one share of stock, which is set by the market. Share price can be used to find a company's total market value, as represented by market capitalization.
Learn More
You may also be interested in these CPHD related companies
CPHD News
$CPHD Target $50 based on new results Artcile link http://stks.co/3yVV May 24
about 4 days ago by Jack25bc
about 4 days ago by Jack25bc
Canaccord Genuity Reiterates a 'Buy' on Cepheid (CPHD); Rolling Out Another Assay
May 24, 8:45AM Street Insider
May 24, 8:45AM Street Insider
$CPHD a new lows, but volume lower than last week, and probably sellers fading away, a possible entry if it holds 52.88 area.
about 8 days ago by woowtrading
about 8 days ago by woowtrading
UPDATE: UBS Investment Research Upgrades Cepheid to Buy; Opportunistic Inflection
May 15, 11:04AM Benzinga
May 15, 11:04AM Benzinga
UPDATE: GARP Research & Securities Downgrades Cepheid to Neutral; Valuation Full
May 14, 11:29AM Benzinga
May 14, 11:29AM Benzinga
GARP Research Downgrades Cepheid (CPHD) to Neutral; Walking A Thin Line
May 14, 10:08AM Street Insider
May 14, 10:08AM Street Insider
Listen to $CPHD Cepheid at Deutsche Bank AG Health Care Conference - live at 10:00 AM, ondemand after - http://stks.co/3k3V
about 19 days ago by earningscast
about 19 days ago by earningscast
$CPHD http://stks.co/3aR0 If it breaks todays lod tomorrow.... will short it.
about 28 days ago by Bav111
about 28 days ago by Bav111
GARP Research Of In Defense on Cepheid (CPHD); Franchise Remains Solid Plus Progress In Pipeline
Apr 25, 12:57PM Street Insider
Apr 25, 12:57PM Street Insider
UBS Maintains a 'Neutral' on Cepheid (CPHD); Solid Top-Line Eclipsed by Below-Consensus EPS
Apr 20, 12:56PM Street Insider
Apr 20, 12:56PM Street Insider
Canaccord Genuity Reiterates a 'Buy' on Cepheid (CPHD); Pick Up Shares on Weakness
Apr 20, 8:51AM Street Insider
Apr 20, 8:51AM Street Insider
$CPHD's John Bishop wins the no-spin award for the week. Described this quarter's bottom line as "less than satisfactory to say the least."
about 39 days ago by bradloncar
about 39 days ago by bradloncar
News related to $CPHD: 'Cepheid cuts annual outlook after taking 1Q loss' http://stks.co/3QPR
about 39 days ago by TradeBot
about 39 days ago by TradeBot
Listen to $CPHD Q1 2012 earnings call - live at 05:00 PM, ondemand after - http://stks.co/3QMv
about 39 days ago by earningscast
about 39 days ago by earningscast
Cepheid, Inc. (CPHD) Reports In-Line Q1 Loss; Guides FY12 EPS Above Views
Apr 19, 4:08PM Street Insider
Apr 19, 4:08PM Street Insider
Canaccord Genuity on Life Sciences/Biomedical Devices & Services: Pipelines To Lead Way Through Q1
Apr 18, 10:25AM Street Insider
Apr 18, 10:25AM Street Insider
News related to $CPHD: 'Quidel rises on new clearance for flu test' http://stks.co/31m2
about 67 days ago by TradeBot
about 67 days ago by TradeBot
Approaching a pivot after a few week of earnings breakout consolidation $CPHD http://chart.ly/rflpbdb
about 70 days ago by ivanhoff
about 70 days ago by ivanhoff
$CPHD http://stks.co/2uxy flagging with a trigger long over 43 to a MM at 47
about 72 days ago by harmongreg
about 72 days ago by harmongreg
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| CPHD | 38.47 | +0.38 | +1.00% | 2.519B |
| DLB | 43.96 | -0.04 | -0.09% | 4.777B |
| DLA | 14.17 | -0.03 | -0.21% | 119.74M |
| DL | 3.40 | -0.07 | -2.02% | 120.60M |
| DKA | 21.58 | -0.07 | -0.32% | |
| DK | 16.91 | +0.47 | +2.86% | 983.49M |
| DCOM | 13.34 | +0.04 | +0.30% | 469.17M |
| DCM | 15.83 | -0.05 | -0.31% | 65.64B |
| DCIX | 7.07 | -0.02 | -0.28% | 163.18M |
| DCI | 36.12 | -0.15 | -0.41% | 5.379B |